Read + Share
Schreiber S, Aden K, Bernardes JP, Conrad C, et al. Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients
with active inflammatory bowel disease. Gastroenterology 2021 Mar 2. pii: S0016-5085(21)00467.
PMID: 33667488
|
 |
|
